Summary
- Current Price
- As of today, SGMO price is $0.07
- Current Price All-Time High
- SGMO price is currently -99.86% below its historical high of $51.38 set on
- Market Cap
- SGMO current market cap is $31M, down -78.80% year-over-year
- Revenue
- SGMO current annual revenue is $39.55M, down -31.57% year-over-year
- Next Earnings
- As of today, the next earnings release for SGMO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Sangamo Therapeutics, Inc. |
| Ticker | NASDAQ: SGMO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sangamo.com |
| Employees | 183 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $0.07 | ||
| Price, 1D Change | - | |
| $31M | ||
| - | ||
| - | ||
| 1.89 | ||
| $39.55M | ||
| Revenue, 1Y Change | -31.57% | |
| -$0.44 | ||
| EPS, 1Y Change | +9.66% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.44 | ||
| EPS Estimate | -$0.30 | N/A |
| EPS Est. Change | +31.62% | N/A |
| $39.55M | ||
| Revenue Estimate | $10.00M | N/A |
| Revenue Est. Change | -74.72% | N/A |
| $0.07 | ||
| Price Target | $1.50 | - |
| Price Tgt. Change | +1,927.03% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.49 | - | |
| -$0.37 | -$0.44 | -17.52% | |
| -$0.30 | N/A | +31.62% | |
| -$0.10 | N/A | +77.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $62.02M | $57.80M | -6.81% | |
| $65.55M | $39.55M | -39.66% | |
| $10.00M | N/A | -74.72% | |
| $70.85M | N/A | +79.13% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -86.04% | ||
| -93.73% | ||
| -78.80% | ||
| -85.33% | ||
| -31.57% | ||
| -64.46% | ||
| +9.66% | ||
| +64.79% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $0.07 | ||
| $0.38 | ||
| $0.15 | ||
| $0.36 | ||
| $0.17 | ||
| -$0.03 | ||
| 1.89 | ||
| $0.02 | ||
| 29.13 | ||
| 287.75% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $39.55M | ||
| -$0.44 | ||
| $31.95M | ||
| 80.78% | ||
| -$108.00M | ||
| -273.07% | ||
| -$122.93M | ||
| -310.81% | ||
| -$100.40M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -1.88 | ||
| 0.84 | ||
| 0.84 | ||
| - | ||
| 2 | ||
| -42.77 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 0.89 | ||
| -1.62 | ||
| -0.21 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$14.27M | ||
| $20.95M | ||
| $60.52M | ||
| $35.83M | ||
| $74.78M | ||
| $42.47M | ||
| $26.80M | ||
| $1.70M | ||
| $14.44M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $162.48M | ||
| $139.95M | ||
| $7.60M | ||
| $0.00 | ||
| $7.60M | ||
| $0.00 | ||
| -$568.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$97.21M | ||
| -$102.00K | ||
| $70.75M | ||
| $102.00K | ||
| -$97.31M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Truist Securities | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with SGMO
FAQ
- What is the ticker symbol for Sangamo Therapeutics, Inc.?
- The ticker symbol for Sangamo Therapeutics, Inc. is NASDAQ:SGMO
- Does Sangamo Therapeutics, Inc. pay dividends?
- No, Sangamo Therapeutics, Inc. does not pay dividends
- What sector is Sangamo Therapeutics, Inc. in?
- Sangamo Therapeutics, Inc. is in the Healthcare sector
- What industry is Sangamo Therapeutics, Inc. in?
- Sangamo Therapeutics, Inc. is in the Biotechnology industry
- What country is Sangamo Therapeutics, Inc. based in?
- Sangamo Therapeutics, Inc. is headquartered in United States
- When did Sangamo Therapeutics, Inc. go public?
- Sangamo Therapeutics, Inc. initial public offering (IPO) was on April 6, 2000
- Is Sangamo Therapeutics, Inc. in the S&P 500?
- No, Sangamo Therapeutics, Inc. is not included in the S&P 500 index
- Is Sangamo Therapeutics, Inc. in the NASDAQ 100?
- No, Sangamo Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Sangamo Therapeutics, Inc. in the Dow Jones?
- No, Sangamo Therapeutics, Inc. is not included in the Dow Jones index
- When was Sangamo Therapeutics, Inc. last earnings report?
- Sangamo Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Sangamo Therapeutics, Inc. report earnings?
- The date for Sangamo Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- SGMO Official Website www.sangamo.com
- SGMO Profile on Yahoo Finance finance.yahoo.com/quote/SGMO
- SGMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgmo
